Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis

NCT02903212 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire de Besancon